Dr. Onyee Chan, MD
Claim this profileMoffitt Cancer Center
Studies T-Lymphoblastic Leukemia/Lymphoma
Studies Acute Myeloid Leukemia
8 reported clinical trials
11 drugs studied
Area of expertise
1T-Lymphoblastic Leukemia/Lymphoma
FLT3 positive
FLT3 negative
CD33 positive
2Acute Myeloid Leukemia
FLT3 positive
FLT3 negative
CD33 positive
Affiliated Hospitals
Clinical Trials Onyee Chan, MD is currently running
Venetoclax + CLAG-M
for AML
This multicenter, open-label phase II study combines CLAG-based therapy with or without venetoclax in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) in order to improve measurable residual disease (MRD) clearance and event-free survival. Investigators hypothesize that the addition of venetoclax to CLAG-M in patients with relapsed or refractory AML is safe, and superior to CLAG-M alone in improving patient outcomes.
Recruiting1 award Phase 26 criteria
REM-422
for Acute Myeloid Leukemia and Higher Risk MDS
The goal of this study is to determine the safety and antitumor effects of REM-422, a MYB mRNA degrader, in people with Higher Risk MDS and relapsed/refractory AML
Recruiting1 award Phase 1
More about Onyee Chan, MD
Clinical Trial Related1 year of experience running clinical trials · Led 8 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Onyee Chan, MD has experience with
- Vyxeos
- Venetoclax
- Gilteritinib
- Azacitidine
- Decitabine
- Gemtuzumab Ozogamicin
Breakdown of trials Onyee Chan, MD has run
T-Lymphoblastic Leukemia/Lymphoma
Acute Myeloid Leukemia
Myeloid Leukemia
Myelodysplastic syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Onyee Chan, MD specialize in?
Onyee Chan, MD focuses on T-Lymphoblastic Leukemia/Lymphoma and Acute Myeloid Leukemia. In particular, much of their work with T-Lymphoblastic Leukemia/Lymphoma has involved FLT3 positive patients, or patients who are FLT3 negative.
Is Onyee Chan, MD currently recruiting for clinical trials?
Yes, Onyee Chan, MD is currently recruiting for 6 clinical trials in Tampa Florida. If you're interested in participating, you should apply.
Are there any treatments that Onyee Chan, MD has studied deeply?
Yes, Onyee Chan, MD has studied treatments such as Vyxeos, Venetoclax, Gilteritinib.
What is the best way to schedule an appointment with Onyee Chan, MD?
Apply for one of the trials that Onyee Chan, MD is conducting.
What is the office address of Onyee Chan, MD?
The office of Onyee Chan, MD is located at: Moffitt Cancer Center, Tampa, Florida 33612 United States. This is the address for their practice at the Moffitt Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.